This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Fundacio Privada Institutcio Catalana De Recerca I Estudis Avancats (Icrea), Fundació Privada Institut D'investigatió Oncológica De Vall Hebron (Vhio), Fundacio Privada Institut D'investigatio Oncologica Vall De'hebron (Vhio). Active years: 2018-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
1 out of 1 
1 out of 1 Years Active: 2018-2024
Title: Silvia Penuelas Prieto: Innovator in Cancer Treatment
Introduction
Silvia Penuelas Prieto is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of cancer research, particularly in the development of therapeutic agents aimed at treating diseases associated with undesired cell proliferation. With a total of 2 patents, her work is paving the way for innovative cancer therapies.
Latest Patents
Silvia's latest patents focus on therapeutic agents for the treatment of diseases associated with undesired cell proliferation. One of her inventions is based on the observation that LIF can activate the self-renewal of tumor stem cells in cancer, especially gliomas. This discovery indicates that inhibiting LIF and IL-6 type cytokines can be utilized in therapeutic compositions for treating such diseases. Additionally, her invention includes a method for identifying compounds that can block or inhibit the proliferation of stem cells. It also provides an in vitro method for diagnosing diseases related to unwanted cell proliferation and determining a subject's predisposition to such diseases.
Another significant patent involves inhibitors of the expression and/or activity of LIF for cancer treatment. This invention offers an in vitro method for designing customized therapy for cancer patients. It involves quantifying the expression levels of LIF in patients and comparing these levels with control values. If the expression levels of LIF are higher than the control values, an inhibitory agent of LIF is administered to the patient.
Career Highlights
Silvia has worked with notable institutions such as the Fundació Privada Institut Català de Recerca i Estudis Avançats (ICREA) and the Fundació Privada Institut d'Investigació Oncològica de Vall Hebron (VHIO). Her work in these organizations has been instrumental in advancing cancer research and developing innovative treatment options.
Collaborations
Throughout her career, Silvia has collaborated with esteemed colleagues, including Joan Seoane Suarez and José Baselga Torres. These collaborations have further enriched her research and contributed to her success as an inventor.
Conclusion
Silvia Penuelas Prieto is a trailblazer in the field of cancer treatment, with her innovative patents and research making a significant impact. Her dedication to advancing therapeutic options for patients suffering from cancer is commendable and highlights the importance of innovation in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile